
The revised conflict-of-interest disclosures include new information about financial ties between top cancer researchers and for-profit companies.
By CHARLES ORNSTEIN and KATIE THOMAS from NYT Health https://ift.tt/2OTtAZz
via IFTTT
Research, Drugs (Pharmaceuticals), Boards of Directors
Source The New York Times
Làm đẹp Blog 247
Không có nhận xét nào:
Đăng nhận xét